Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Both semaglutide and metformin can trigger gastrointestinal issues, but the intensity and frequency of these side effects vary between the two
Semaglutide is the established GLP-1 receptor agonist with three FDA approvals and the most comprehensive clinical evidence base in its class
Does DSIP have a Certificate of Analysis
Edens semaglutide program is built around these injectable options, which combine strong clinical evidence with a simple, once-weekly dosing schedule
Research Use Only This product is intended for laboratory and scientific research purposes only
US$ 26.90
US$ 26.69
US$ 23.63
